Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. - Wikidata - awgldk - TriplyDB

Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.

Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.

http://www.wikidata.org/entity/Q37051227

about

A systematic review and meta-analysis of the ability of analgesic drugs to reduce metastasis in experimental cancer models The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer Increased μ-opioid receptor expression in metastatic lung cancer Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer.A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection.Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer.Morphine promotes cancer stem cell properties, contributing to chemoresistance in breast cancer.Influence of morphine on pericyte-endothelial interaction: implications for antiangiogenic therapy Morphine stimulates platelet-derived growth factor receptor-β signalling in mesangial cells in vitro and transgenic sickle mouse kidney in vivo.The ERK1/2 signaling pathway is involved in sulfur dioxide preconditioning-induced protection against cardiac dysfunction in isolated perfused rat heart subjected to myocardial ischemia/reperfusion.Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer.Patient optimization for gastrointestinal cancer surgery.The effects of anesthetics on tumor progression.Can anesthetic-analgesic technique during primary cancer surgery affect recurrence or metastasis?Morphine enhances renal cell carcinoma aggressiveness through promotes survivin level.Opioids and opioid receptors orchestrate wound repair.Dasatinib and Doxorubicin Treatment of Sarcoma Initiating Cells: A Possible New Treatment Strategy.Chronic opioid therapy in long-term cancer survivors.Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination Topical fentanyl stimulates healing of ischemic wounds in diabetic rats.Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.Could Perioperative Opioid Use Increase the Risk of Cancer Progression and Metastases?The effects of intra- and post-operative anaesthesia and analgesia choice on outcome after gastric cancer resection: a retrospective study.Perioperative epidural analgesia reduces cancer recurrence after gastro-oesophageal surgery.microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway.

P2860

Q26800267-E70636E1-D216-4B37-BBD0-CB62311B2A18 Q28541351-B282E132-3971-4DD2-89F5-2E216C990FC4 Q33951500-EAC44973-58E6-43B6-9B18-F7DE3F40D111 Q33951506-6AD7D2AC-A5EB-40F0-9529-F4B496C5F878 Q35000444-8B1BE784-7AB4-4135-8715-C04C1F674BAF Q35011905-9C99342D-33DF-4A87-A6AC-9240C04DEACE Q35551918-F0C945E8-DB2C-4C4A-89BC-FA5AF86D1225 Q35725355-18EC2D30-C400-4275-BEC0-B4C385D1F9BD Q37308492-3B8FDD1F-7B15-45CE-8576-7A1E1C09EC28 Q37375425-4BF14EDE-D67E-423B-9CE2-78AB8879F39D Q37573308-2F8E5245-C0A7-4CAC-910A-6B57438F9D39 Q38061009-14A93CAF-FF54-4AEF-A5CF-8E990ADAC47F Q38092641-1B3799CC-0D01-4638-9976-778A1C97E055 Q38615477-7D4DB563-5718-4BE1-A4F6-41184D4C0AE9 Q38730049-37D966AA-0AF0-4D5E-935D-9F709A939608 Q38758611-CC8A2393-C406-4075-AD42-E3890413E3FB Q38801464-E1DA2667-D688-4836-8201-CBFFCA041472 Q38904553-5B405F23-16BE-475C-A062-21BB31D5A4EF Q38970689-CBEF2CF0-D2C9-4165-AFEC-CDDF911BCA90 Q40597108-0B800E91-6471-42D1-85AA-D1BBC47AF7B2 Q41460733-5B4E6C92-2A8C-4330-B731-DBDD4EFC3B2D Q41644051-99D6B8CC-2E83-4716-AE4B-B09AC852CC8D Q42365359-DD36C7F3-6165-43AD-A4F4-D86E32DD6904 Q45100494-A20DBCF1-3661-4210-A083-50828372C158 Q49646793-78CE78D7-49E9-4B3F-A7FC-E811D69E7E9E

P2860

Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.

http://www.wikidata.org/entity/Q37051227

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 October 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Morphine-induced epidermal gro ...... in non-small cell lung cancer.

@en

Morphine-induced epidermal gro ...... in non-small cell lung cancer.

@nl

type

label

Morphine-induced epidermal gro ...... in non-small cell lung cancer.

@en

Morphine-induced epidermal gro ...... in non-small cell lung cancer.

@nl

prefLabel

Morphine-induced epidermal gro ...... in non-small cell lung cancer.

@en

Morphine-induced epidermal gro ...... in non-small cell lung cancer.

@nl

P1433

Q37051227-8E09CF0C-F022-4460-8C02-92DD4E88CC7C

P1476

Q37051227-02131AD0-90FC-4EA5-AF88-E09EE1616468

P2093

Q37051227-107C6D87-5744-4B1A-A4B8-10DE31396DC6

Q37051227-406CA9A1-7C50-4506-A97D-D02E7433BA0B

Q37051227-753500C6-C9D3-41F4-8B06-ECD34747746D

Q37051227-796EA1AE-883B-4906-A9E7-03454D38970C

Q37051227-8884323F-FC59-4C94-B51E-F4D17A7FC104

Q37051227-B21FAA29-65F8-4A79-9BE8-B80516E784D8

Q37051227-C66C28E6-B81B-4D7E-B6F6-8CE621330EFE

Q37051227-EF17CE8E-F59A-435B-9ECF-2DA95E18D656

Q37051227-F9C560CC-F25E-4C93-95C1-9BEB18A866D8

Q37051227-FAC6DB01-22FD-49B9-815D-7115BA7094A1

P2860

Q37051227-0009BD20-B0BA-45E1-B71F-0D29885925A1

Q37051227-07CA8050-E55D-450C-9ECD-4A54F827C731

Q37051227-09C2653A-8132-4096-A7DB-5731957665FA

Q37051227-1026F90B-016C-471B-BDBB-95AAF87287A8

Q37051227-1A6AF0C6-D59F-4102-A857-AC2BF439C450

Q37051227-36895A56-BBBA-43C1-9372-D56D3BEC4400

Q37051227-369DF49E-F82E-48A2-82EF-5F3E0327FA96

Q37051227-497A0291-D8EA-4D8F-9D25-118938C88AA9

Q37051227-4B872318-9096-4862-9F1F-03E62E24EB06

Q37051227-4D3E1BE8-D3CF-42CF-9C85-8335BF1BCA22

P304

Q37051227-D80B70C6-DE27-4B39-ADBA-6CA5561290C1

P31

Q37051227-C8E599ED-F223-4CF4-B363-19F5D74882E7

P356

Q37051227-269623C0-2C62-4FAC-8FDE-E33441105411

P407

Q37051227-8AE46AA5-268B-47FA-9F48-30C99BA1C58A

P433

Q37051227-F0939B1F-D147-40CC-BB43-CF78D50A70DE

P478

Q37051227-DB0A9CCD-9F29-4730-9151-88ADB28107E7

P577

Q37051227-97FC55E4-7C0F-4CA1-8831-DEBC3F7C6306

P698

Q37051227-7057338A-B7EC-4940-AB52-AF4E265B295B

P932

Q37051227-BC831E85-C2F9-4EA3-9C24-ED7F63073F82

P356

ANE.0B013E318232B35A

P1433

Anesthesia & Analgesia

P1476

Morphine-induced epidermal gro ...... in non-small cell lung cancer.

@en

P2093

Chunsheng Chen

http://www.w3.org/2001/XMLSchema#string

Gloria Niehans

http://www.w3.org/2001/XMLSchema#string

Julia Nguyen

http://www.w3.org/2001/XMLSchema#string

Kalpna Gupta

http://www.w3.org/2001/XMLSchema#string

Katherine N Johnson

http://www.w3.org/2001/XMLSchema#string

Naomi Fujioka

http://www.w3.org/2001/XMLSchema#string

Robert A Kratzke

http://www.w3.org/2001/XMLSchema#string

Teena Pasrija

http://www.w3.org/2001/XMLSchema#string

Vinita Gupta

http://www.w3.org/2001/XMLSchema#string

Yunfang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines

Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Met, metastasis, motility and more

P304

1353-1364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1213/ANE.0B013E318232B35A

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22003224

http://www.w3.org/2001/XMLSchema#string

P932

3725599

http://www.w3.org/2001/XMLSchema#string